Global Large Bore Vascular Closure Devices Market Size By Type (Passive Closure Devices, Active Closure Devices), By Application (Femoral Arterial, Transradial Arterial), By Region, And Segment Foreca...

lobal Large Bore Vascular Closure Devices Market Report Description

The Global Large Bore Vascular Closure Devices Market was valued at USD 792.4 million in 2023 and is projected to reach USD 1,645.8 million by 2031, growing at a CAGR of 9.6% during the forecast period of 2023–2031. The market's growth is driven by the increasing adoption of transcatheter procedures, such as TAVR and EVAR, which require reliable and efficient closure of large bore access sites. The rising prevalence of cardiovascular diseases and the growing elderly population further contribute to the increased demand for large bore vascular closure devices (VCDs). These devices play a critical role in achieving rapid hemostasis, minimizing complications, and reducing hospital stays, thereby enhancing patient outcomes and procedural efficiency.

Drivers:

1. Rise in Transcatheter Interventions:

The shift from surgical to minimally invasive procedures, particularly in structural heart and endovascular repair, has created a surge in the use of large bore vascular closure devices to ensure safe arterial closure post-intervention.

2. Advancements in Device Design:

Technological innovations are enhancing the effectiveness, safety, and ease of deployment of large bore VCDs. Bioabsorbable materials and percutaneous systems have significantly improved patient recovery times and reduced procedural complexity.

3. Growing Cardiovascular Disease Burden:

An increase in conditions such as aortic aneurysms and valvular heart diseases has amplified the number of large bore access procedures, fueling demand for reliable closure systems.

Restraints:

1. High Device Costs:

The premium pricing associated with large bore closure devices and associated procedural costs can hinder adoption, particularly in cost-sensitive healthcare systems and emerging markets.

2. Device-Related Complications:

Despite advancements, risks like vascular injury, bleeding, and device failure persist, necessitating skilled operators and robust post-procedure management, which may limit broader adoption.

Opportunity:

1. Emerging Markets and Increasing Healthcare Access:

Rapid expansion of healthcare infrastructure and growing adoption of minimally invasive interventions in Asia-Pacific and Latin America present significant growth opportunities.

2. Integration with Imaging and Navigation Systems:

Future trends include combining closure devices with real-time imaging or robotic assistance to improve deployment accuracy and minimize risks.

Market by System Type Insights:

Based on system type, the Suture-Based Vascular Closure Devices segment held the largest market share in 2023. These devices offer strong and durable hemostasis, especially for high-risk or obese patients. However, the Plug-Based Closure Devices segment is projected to grow at the fastest CAGR due to their ease of use and reduced deployment time, which can significantly enhance procedural throughput in high-volume centers.

Market by End-Use Insights:

In 2023, Hospitals dominated the market by end-use, accounting for over 60% of the total revenue. Hospitals remain the primary setting for structural heart and peripheral vascular procedures. The Ambulatory Surgical Centers (ASCs) segment is expected to witness notable growth as minimally invasive procedures become increasingly feasible in outpatient settings, reducing costs and improving patient convenience.

Market by Regional Insights:

North America led the global large bore vascular closure devices market in 2023, driven by robust procedural volumes, established healthcare infrastructure, and favorable reimbursement policies. However, Asia-Pacific is projected to exhibit the fastest growth, fueled by the expanding elderly population, rising awareness of advanced therapies, and increased healthcare spending in countries such as China, India, and Japan.

Competitive Scenario:

Key players in the Global Large Bore Vascular Closure Devices Market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Teleflex Incorporated, and Essential Medical, Inc. These companies are actively engaged in developing next-generation closure systems, expanding geographic presence, and leveraging strategic partnerships.

Key Developments:

In 2023, Abbott launched a new iteration of its Perclose ProGlide™ closure system optimized for larger bore access management in complex structural heart procedures.

In 2024, Terumo announced clinical trial results demonstrating superior safety outcomes for its MANTA™ Vascular Closure Device, paving the way for regulatory approvals in new regions.

In 2025, Teleflex completed the acquisition of a startup specializing in biodegradable vascular closure technologies, aiming to expand its next-gen product portfolio.

Scope of Work – Global Large Bore Vascular Closure Devices Market

Report Metric Details

Market Size (2023) USD 792.4 million

Projected Market Size (2031) USD 1,645.8 million

CAGR (2023–2031) 9.6%

Market Segments System Type (Suture-Based, Plug-Based, Others), End-Use (Hospitals, ASCs, Others), Region

Growth Drivers Rise in transcatheter procedures, aging population, device innovation

Opportunities Expansion in emerging mark